Hydrix (ASX:HYD) raises A$3.89m at half a cent to fund defence pivot

A 6-for-1 entitlement offer buys runway, but the dilution math now defines the story

Hydrix Limited (ASX:HYD) has closed the institutional leg of its accelerated entitlement offer, banking A$3.89 million at half a cent per share. The full raise targets A$8.183 million, with the retail component opening 25 May and closing 5 June.

The terms tell their own story. Six new shares for every one held, priced at A$0.005, with a free attaching option exercisable at one cent and running out to mid-2029. That is a structure designed to get a deal done, not to flatter the existing register.

Existing institutional holders did not take up their entitlements. The full A$3.89 million was absorbed by new institutions and family offices through the shortfall bookbuild led by Peak Asset Management. That is a meaningful signal about where the old register sat versus where management needs the new one.

The proceeds do real work. Assuming the full A$8.183 million lands, A$4.79 million retires debt and operating liabilities, A$0.78 million covers offer costs, and A$2.61 million becomes working capital aimed at defence technology initiatives.

Why the half-cent price is the whole story

Pricing an offer at A$0.005 with a 6-for-1 ratio is what a balance sheet does when it has run out of softer options. The dilution is severe, the discount is deep, and the structure says Hydrix needed certainty of funding more than price discipline.

Layered on top is a debt-for-equity conversion of up to A$5.435 million in convertible notes and loans. A$5.113 million has already been committed in writing by directors and noteholders, conditional on shareholder approval and the Entitlement Offer clearing A$4 million. That hurdle is now cleared.

Put the two pieces together. Hydrix is rebuilding the capital structure from the bottom up. The bull case is the company emerges debt-light with cash in hand. The bear case is the share count after options and conversions looks very different from today’s.

The defence pivot is the reason this raise needs to work

Hydrix runs three businesses. Services does embedded systems engineering across medtech and defence. Ventures invests in aligned technology companies. Medical focuses on cardiovascular and connected healthcare products.

The announcement explicitly flags an increasing focus on defence technology, and that framing matters. Defence engineering work tends to come with longer contract tails, stickier customers and better margins than commercial medtech, particularly for a small Australian engineering house chasing specialist programs.

Our concern is that the working capital allocation is only A$2.61 million at full subscription. That keeps the lights on and funds selected programs, but it is not a war chest. The defence pivot has to convert into named contracts inside 12 months or this raise simply funds the next one.

What the retail bookbuild will actually reveal

The retail leg seeks A$4.3 million on identical terms, with anything untaken flowing into a shortfall bookbuild on 10 June. Retail offers at deep discounts often see soft direct take-up, so the bookbuild becomes the real price discovery moment. A clean clear at the offer price says the defence narrative is landing. A struggle says it is not, yet.

The Investors Takeaway for Hydrix

Hydrix has bought itself a clean balance sheet and roughly A$2.6 million of working capital in exchange for a sharply diluted register and a lot of new options out to 2029. Whether the trade was worth it depends on what the defence engineering pipeline delivers between now and the EGM in mid-July, and the quarters that follow.

We think the next six months are binary for this name. A named defence contract, even a modest one, would validate the pivot and let the share price work through the option overhang. Investors can find our prior coverage of related themes at stocksdownunder.